Sign in
4

Changes in Ownership

Ascendis Pharma A/S Filed Acc 0001610717-26-000176

EVP & Chief Financial Officer bought 250 shares at $223.32 ($55,830)

From the SEC's structured data for this filing

Trades in this filing

SMITH SCOTT THOMAS · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-29 Purchase : show line 1 in the form +250 $223.32 $55,830 4,267 D
Open-market purchases · 250 sh · avg $223.32 · $55,830
Loading xslF345X06/form4.xml…